Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an ...

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

First Solar ( FSLR) was the worst-performing stock in the S&P 500 when Jefferies lowered its price target, warning that ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

On Wednesday, Bourla is expected to sit down with Starboard after reports early last week that the investment firm had ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

The stock's rise snapped a three-day losing streak.

On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -0.61%) ...

Late afternoon on Tuesday, the Financial Times (FT) published an article stating that Pfizer CEO Albert Bourla plans to meet ...